Shanghai, China

Gang Fu

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Gang Fu: A Focus on Ledipasvir Crystal Development

Introduction

Gang Fu is an accomplished inventor based in Shanghai, China, known for his significant contributions to the pharmaceutical industry. His innovative work focuses on enhancing the quality and effectiveness of pharmaceutical formulations, particularly through the development of novel crystal forms.

Latest Patents

One of Gang Fu's notable patents is for a novel Ledipasvir (LDV) crystal form and its preparation method. This invention involves a unique LDV solvate, which is formed by the interaction of LDV with specific solvents, such as acetonitrile, acetone, and methyl tertiary butyl ether (MTBE). The patent details that this solvate exhibits high purity and superior crystallization properties, along with improved optical stability. The preparation method outlined in the patent is noted for its simplicity and stability, aiming to enhance quality control measures and support industrial applications for LDV-containing drugs.

Career Highlights

Gang Fu is currently associated with Shanghai Forefront Pharmaceutical Co., Ltd., where he applies his expertise to advance pharmaceutical research and development. His work contributes to the improvement of drug quality, which is essential for the efficacy of treatments in patients.

Collaborations

At Shanghai Forefront Pharmaceutical Co., Ltd., Gang Fu collaborates with talented colleagues such as Wei Zhang and Yi Ren. These collaborations play a vital role in fostering innovative approaches to drug formulation and development, as they work together to push the boundaries of pharmaceutical research.

Conclusion

Gang Fu's contributions to the field of pharmaceuticals, particularly through his patent on Ledipasvir crystal forms, exemplify the importance of innovation in developing effective medications. His dedication and collaboration with peers reinforce the commitment to creating high-quality pharmaceutical solutions that enhance patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…